Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre-Reference-Cited by-同舟云学术

Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre

Published:2014-11 Issue: Volume:17 Page:19817
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:Journal of the International AIDS Society

Author:

Borghetti Alberto,Mondi Annalisa,Piccoli Benedetta,Gagliardini Roberta,Lamonica Silvia,Ciccarelli Nicoletta,D'Avino Alessandro,Pallavicini Federico,Cauda Roberto,De Luca Andrea,Fabbiani Massimiliano,Di Giambenedetto Simona

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen;AIDS Research and Human Retroviruses;2022-02-10

2. The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study;Antiviral Therapy;2019

3. Simplification to dual-therapy containing lamivudine and darunavir/ritonavir or atazanavir/ritonavir in HIV-infected patients on virologically suppressive antiretroviral therapy;Infectious Diseases;2017-12-06

4. Long-term clinical experience with darunavir (2007-2015) in a large cohort of HIV-infected patients in Spain;Journal of Medical Virology;2016-06-06

5. Dual Raltegravir–Darunavir/Ritonavir Combination in Virologically Suppressed HIV-1-Infected Patients on Antiretroviral Therapy Including a Ritonavir-Boosted Protease Inhibitor Plus Two Nucleoside/Nucleotide Reverse Transcriptase Inhibitors;HIV Clinical Trials;2016-01-02